论文部分内容阅读
The voltage-gated KCNQ/M-potassium channels play a principal role in controlling neuronal excitability.Mutations or inhibition of KCNQ/M-channels can cause neurological diseases, such as myokymia and bernign familial neonatal convulsions.Therefore, development of specific KCNQ2/3 channels openers may provide a therapeutic strategy for treatment of neuronal excitability disorders.